Ccdc114 Gene Primary Ciliary Dyskinesia Type 20 NGS Genetic DNA Test
Introduction to the Test
The Ccdc114 Gene Primary Ciliary Dyskinesia Type 20 NGS Genetic DNA Test is a cutting-edge diagnostic tool designed to identify genetic mutations associated with primary ciliary dyskinesia (PCD). This condition is characterized by abnormalities in ciliary function, leading to respiratory issues and fertility problems. Early detection through genetic testing is vital for effective management and treatment of the condition.
What the Test Measures
This genetic test specifically analyzes the CCDC114 gene to detect any mutations that may cause primary ciliary dyskinesia. By utilizing Next-Generation Sequencing (NGS) technology, the test provides a comprehensive analysis of the gene, ensuring accurate results.
Who Should Consider This Test?
Individuals experiencing chronic respiratory issues, recurrent infections, or unexplained infertility may benefit from this test. Additionally, those with a family history of PCD or related symptoms should consider genetic testing for a clearer understanding of their health status.
Benefits of Taking the Test
- Accurate diagnosis of primary ciliary dyskinesia.
- Guidance for treatment options and management strategies.
- Informed family planning and genetic counseling.
- Peace of mind through understanding genetic health risks.
Understanding Your Results
Results from the Ccdc114 Gene Primary Ciliary Dyskinesia Type 20 NGS Genetic DNA Test will be provided within 3 to 4 weeks. A genetic counselor will assist in interpreting the results, discussing potential implications for health and family planning.
Test Pricing
| Price Type | Amount (NGN) |
|---|---|
| Discount Price | 400000 |
| Regular Price | 560000 |
Book Your Test Today!
To take the next step in understanding your genetic health, we encourage you to book the Ccdc114 Gene Primary Ciliary Dyskinesia Type 20 NGS Genetic DNA Test. For more information or to schedule your appointment, please call or WhatsApp us at +2348077798758.
